Syngen Biotech Co (ROCO:8279) Cyclically Adjusted FCF per Share: NT$3.26 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:8279 Syngen Biotech Co Ltd ROCO:8279
91 GF Score
Price NT$89.00
GF Value NT$144.63
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Syngen Biotech Co Cyclically Adjusted FCF per Share?

Syngen Biotech Co ROCO:8279 -2.20% 91 Cyclically Adjusted FCF per Share is NT$3.26 as of Mar. 2026. GuruFocus rates ROCO:8279 with a GF Score™ of 91/100 and a GF Value™ of NT$144.63 (Significantly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Syngen Biotech Co's adjusted free cash flow per share for the three months ended in Mar. 2026 was NT$4.139. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is NT$3.26 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Syngen Biotech Co's average Cyclically Adjusted FCF Growth Rate was 48.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-08-08), Syngen Biotech Co's current stock price is NT$89.00. Syngen Biotech Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was NT$3.26. Syngen Biotech Co's Cyclically Adjusted Price-to-FCF of today is 27.30.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Syngen Biotech Co was 156.64. The lowest was 26.56. And the median was 59.61.


Syngen Biotech Co  (ROCO:8279) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Syngen Biotech Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=89.00/3.26
=27.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Syngen Biotech Co was 156.64. The lowest was 26.56. And the median was 59.61.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Syngen Biotech Co Cyclically Adjusted FCF per Share Related Terms


Syngen Biotech Co Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Syngen Biotech Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Syngen Biotech Co Cyclically Adjusted FCF per Share Chart

Syngen Biotech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 1.21 2.17 2.89

Syngen Biotech Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.20 2.07 2.51 2.89 3.26

ROCO:8279 vs VRTX, REGN, RVMD: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Syngen Biotech Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syngen Biotech Co Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Syngen Biotech Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Syngen Biotech Co's Cyclically Adjusted Price-to-FCF falls into.


ROCO:8279
91GF Score
Syngen Biotech Co Ltd ROCO:8279
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Syngen Biotech Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Syngen Biotech Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=4.139/330.2130*330.2130
=4.139

Current CPI (Mar. 2026) = 330.2130.

Syngen Biotech Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -0.163 241.018 -0.223
201609 1.926 241.428 2.634
201612 -1.876 241.432 -2.566
201703 -8.212 243.801 -11.123
201706 0.963 244.955 1.298
201709 0.244 246.819 0.326
201712 1.273 246.524 1.705
201803 0.189 249.554 0.250
201806 -2.991 251.989 -3.919
201809 0.692 252.439 0.905
201812 1.001 251.233 1.316
201903 3.748 254.202 4.869
201906 -1.800 256.143 -2.321
201909 2.407 256.759 3.096
201912 1.782 256.974 2.290
202003 -2.468 258.115 -3.157
202006 -1.987 257.797 -2.545
202009 -2.414 260.280 -3.063
202012 4.925 260.474 6.244
202103 2.259 264.877 2.816
202106 -1.956 271.696 -2.377
202109 5.353 274.310 6.444
202112 4.486 278.802 5.313
202203 0.441 287.504 0.507
202206 -21.110 296.311 -23.525
202209 6.694 296.808 7.447
202212 2.654 296.797 2.953
202303 3.018 301.836 3.302
202306 -1.785 305.109 -1.932
202309 6.946 307.789 7.452
202312 3.672 306.746 3.953
202403 0.783 312.332 0.828
202406 -1.151 314.175 -1.210
202409 5.952 315.301 6.233
202412 4.885 315.605 5.111
202503 1.590 319.799 1.642
202506 -0.932 322.561 -0.954
202509 6.426 324.800 6.533
202512 1.863 324.054 1.898
202603 4.139 330.213 4.139

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of NT$3.26 mean?
Syngen Biotech Co (ROCO:8279) has a Cyclically Adjusted FCF per Share of NT$3.26 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Syngen Biotech Co and its competitors.
Is Syngen Biotech Co's Cyclically Adjusted FCF per Share too high?
Syngen Biotech Co's current Cyclically Adjusted FCF per Share is NT$3.26. Overall, Syngen Biotech Co has a GF Score™ of 91/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Syngen Biotech Co's Cyclically Adjusted FCF per Share compare to VRTX and REGN?
Syngen Biotech Co's Cyclically Adjusted FCF per Share of NT$3.26 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Syngen Biotech Co and its competitors. Syngen Biotech Co's current Cyclically Adjusted FCF per Share is NT$3.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Syngen Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Syngen Biotech Co (ROCO:8279) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$144.63, compared to a current price of NT$89.00 — trading 38.5% below its estimated fair value. The current Cyclically Adjusted FCF per Share is NT$3.26. Syngen Biotech Co's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Syngen Biotech Co (ROCO:8279), the current Cyclically Adjusted FCF per Share is NT$3.26 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Syngen Biotech Co (ROCO:8279) Overvalued in 2026?

Based on GuruFocus' analysis, Syngen Biotech Co stock appears to be undervalued. The current stock price of NT$89.00 is trading 38.5% below its estimated GF Value™ of NT$144.63. GuruFocus considers Syngen Biotech Co to be Significantly Undervalued.

Key valuation signals for ROCO:8279:

  • Cyclically Adjusted FCF per Share: NT$3.26
  • GF Value™: NT$144.63 vs. price of NT$89.00 (38.5% below fair value)
  • GF Score™: 91/100 with 3 warning signs

No single metric tells the full story. See the ROCO:8279 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Syngen Biotech Co Business Description

Address Building A, NO.154, Kai-Yuan Road, Xinying District, Tainan, TWN, 73055
Syngen Biotech Co Ltd is a biotechnology company. It is engaged in the manufacturing, sales, and trading of microbial pharmaceutical raw materials. It also provides the design and development of health food and biochemical nutrition. The company's products include pharmaceutical ingredients, nutritional ingredients, biology fermentation products, biology agriculture and aquaculture products.
91GF Score

Get the complete analysis for ROCO:8279

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$89.00
Price
NT$144.63
GF Value